Tag: SARS CoV2
Indian researchers unveil structure of key protein in COVID-19 virus
The IIT Mandi team has experimentally studied the structural conformations of SARS-CoV-2 NSP1 under various conditions – in an organic solvent, membrane mimetic environment, and inside liposomes...........................
COVID-19: How data can help generate public health response?
Digitizing patient data at the hospitals would not take much time with the help of technological tools like scanners and spreadsheets, writes Dr Monika Chaudhary.........................
J Mitra launches India’s first Covid-19 neutralizing antibody test
Covid-19 Neutralizing Antibody Microlisa Elisa Test is the first commercial laboratory test to detect neutralizing antibodies against SARS-CoV-2, the virus that causes Covid-19......................
IIT Madras researchers study the high transmission potential of Coronavirus
Studying the SARS-CoV-2, which causes COVID-19, using various computational tools, the team set out to understand how spike proteins of these different virus strains interact with the human cells.....................
DBT funds phase-1 trials of Gennova’s novel mRNA-based COVID-19 vaccine
Vaccine Discovery Programme supported by the Department of Biotechnology under the Mission COVID Suraksha, implemented by BIRAC, moves into clinical trials...............
COVID-19 second wave won’t be severe but shorter & might fizzle...
The experts at Neuberg’s Panel discussion on “Coronavirus – variants and vaccination” said there will be the second wave of Coronavirus however it will not be as severe as the first one and it will fizzle off sooner....................
Pfizer & BioNTech COVID-19 vaccine candidate achieves success in phase 3...
The vaccine candidate was found to be more than 90% effective in preventing COVID-19 in participants without evidence of prior SARS-CoV-2 infection in the first interim efficacy analysis...................
Tata Group to launch India’s first CRISPR Covid-19 test, powered by...
India’s first CRISPR Covid-19 test, developed by the Tata Group and CSIR-IGIB, has been approved for use in India....................
Hematological disorders associated with Covid-19
Dr Niti Raizada, Director - Medical Oncology and Hemato-Oncology, Fortis Hospital, Bengaluru takes us through a plethora of hematological disorders that form the leading cause of morbidity and mortality associated with COVID-19...................
Premas Biotech SARS-Cov-2 vaccine candidate moves ahead for animal trials
The four-week placebo-controlled, blinded and randomized tests to be conducted in mice will seek to evaluate safety and examine immune response dose titration in the rodent model................